ERBB2 and breast carcinoma: Similar phenomena have been observed in breast cancer mouse models, where disseminated tumors exhibit significant variability in vascular density (CD31) and tumor marker expression (mKate, Her2/neu), while primary tumors show relatively less heterogeneity (12).